Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 40 citing articles:

Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 129
Glycogen Synthase Kinase-3 Inhibitors: Preclinical and Clinical Focus on CNS-A Decade Onward
Sara Arciniegas Ruiz, Hagit Eldar-Finkelman
Frontiers in Molecular Neuroscience (2022) Vol. 14
Open Access | Times Cited: 81
GSK-3β, FYN, and DYRK1A: Master Regulators in Neurodegenerative Pathways
Stefania Demuro, Rita Maria Concetta Di Martino, José Antonio Ortega, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 9098-9098
Open Access | Times Cited: 61
π–Cation Interactions in Molecular Recognition: Perspectives on Pharmaceuticals and Pesticides
Zhibin Liang, Qing X. Li
Journal of Agricultural and Food Chemistry (2018) Vol. 66, Iss. 13, pp. 3315-3323
Open Access | Times Cited: 61
Targeting Tau Hyperphosphorylation via Kinase Inhibition: Strategy to Address Alzheimer's Disease
Ahmad Abu Turab Naqvi, Gulam Mustafa Hasan, Md. Imtaiyaz Hassan
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 12, pp. 1059-1073
Closed Access | Times Cited: 52
Natural products targeting mitochondria: emerging therapeutics for age-associated neurological disorders
Zhibin Liang, António Currais, David Soriano‐Castell, et al.
Pharmacology & Therapeutics (2020) Vol. 221, pp. 107749-107749
Open Access | Times Cited: 51
Glycogen Synthase Kinase 3β Involvement in Neuroinflammation and Neurodegenerative Diseases
Teresa Gianferrara, Eleonora Cescon, Ilenia Grieco, et al.
Current Medicinal Chemistry (2022) Vol. 29, Iss. 27, pp. 4631-4697
Closed Access | Times Cited: 30
Anti-oxidative stress and cognitive improvement of a semi-synthetic isoorientin-based GSK-3β inhibitor in rat pheochromocytoma cell PC12 and scopolamine-induced AD model mice via AKT/GSK-3β/Nrf2 pathway
Yijing Zhao, Changhong He, Shaozhen Hu, et al.
Experimental Neurology (2024) Vol. 380, pp. 114881-114881
Closed Access | Times Cited: 6
Structure-activity relationship (SAR) studies of synthetic glycogen synthase kinase-3β inhibitors: A critical review
Man Xu, S.L. Wang, Li Zhu, et al.
European Journal of Medicinal Chemistry (2018) Vol. 164, pp. 448-470
Closed Access | Times Cited: 57
Glycogen Synthase Kinase 3 (GSK3): Its Role and Inhibitors
Pankaj Wadhwa, Priti Jain, Hemant R. Jadhav
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 17, pp. 1522-1534
Closed Access | Times Cited: 47
Progress in Target Drug Molecules for Alzheimer's Disease
Jiayang Xie, Ruirui Liang, Yan‐Jiang Wang, et al.
Current Topics in Medicinal Chemistry (2019) Vol. 20, Iss. 1, pp. 4-36
Closed Access | Times Cited: 43
Development of inhibitors targeting glycogen synthase kinase-3β for human diseases: Strategies to improve selectivity
Junxia Wei, Jiaxing Wang, Jifa Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 236, pp. 114301-114301
Closed Access | Times Cited: 27
Targeting glycogen synthase kinase-3β for Alzheimer's disease: Recent advances and future Prospects
Zimeng Cheng, Tianyue Han, Jingtong Yao, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116065-116065
Closed Access | Times Cited: 15
Impact of GSK-3β and CK-1δ on Wnt signaling pathway in alzheimer disease: A dual target approach
Vinita Sharma, Prabodh Chander Sharma, Jurnal Reang, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107378-107378
Closed Access | Times Cited: 5
Isoorientin, a GSK-3β inhibitor, rescues synaptic dysfunction, spatial memory deficits and attenuates pathological progression in APP/PS1 model mice
Xiaoqin Tan, Zhibin Liang, Yingui Li, et al.
Behavioural Brain Research (2020) Vol. 398, pp. 112968-112968
Open Access | Times Cited: 39
Fragment-based drug discovery and biological evaluation of novel cannabinol-based inhibitors of oxytosis/ferroptosis for neurological disorders
Zhibin Liang, Alec Candib, David Soriano‐Castell, et al.
Redox Biology (2024) Vol. 72, pp. 103138-103138
Open Access | Times Cited: 4
Rosmarinic Acid Derivatives’ Inhibition of Glycogen Synthase Kinase-3β Is the Pharmacological Basis of Kangen-Karyu in Alzheimer’s Disease
Pradeep Paudel, Su Hui Seong, Yajuan Zhou, et al.
Molecules (2018) Vol. 23, Iss. 11, pp. 2919-2919
Open Access | Times Cited: 29
Arylbenzofurans from the Root Bark of Morus alba as Triple Inhibitors of Cholinesterase, β-Site Amyloid Precursor Protein Cleaving Enzyme 1, and Glycogen Synthase Kinase-3β: Relevance to Alzheimer’s Disease
Pradeep Paudel, Su Hui Seong, Yajuan Zhou, et al.
ACS Omega (2019) Vol. 4, Iss. 4, pp. 6283-6294
Open Access | Times Cited: 29
1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a Selective and Potent Dual Inhibitor of Soluble Epoxide Hydrolase and p38 Kinase Intervenes in Alzheimer’s Signaling in Human Nerve Cells
Zhibin Liang, Bei Zhang, Meng Xu, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 9, pp. 4018-4030
Open Access | Times Cited: 29
Isoorientin Affects Markers of Alzheimer's Disease via Effects on the Oral and Gut Microbiota in APP/PS1 Mice
Zhongbao Zhang, Xiaoqin Tan, Xiaorong Sun, et al.
Journal of Nutrition (2021) Vol. 152, Iss. 1, pp. 140-152
Open Access | Times Cited: 21
Natural variation of ZmCGT1 is responsible for isoorientin accumulation in maize silk
Xiaorong Sun, Xiaofeng Xue, Xiaqing Wang, et al.
The Plant Journal (2021) Vol. 109, Iss. 1, pp. 64-76
Open Access | Times Cited: 18
Distribution of Four Bioactive Flavonoids in Maize Tissues of Five Varieties and Correlation with Expression of the Biosynthetic Genes
Zhongbao Zhang, Zhibin Liang, Longfei Yin, et al.
Journal of Agricultural and Food Chemistry (2018) Vol. 66, Iss. 40, pp. 10431-10437
Closed Access | Times Cited: 22
Design, synthesis and biological evaluation of novel copper-chelating acetylcholinesterase inhibitors with pyridine and N-benzylpiperidine fragments
Yeheng Zhou, Wei Sun, Jiale Peng, et al.
Bioorganic Chemistry (2019) Vol. 93, pp. 103322-103322
Closed Access | Times Cited: 21
Glycogen synthase kinase-3β inhibitors as a novel promising target in the treatment of cancer: Medicinal chemistry perspective
Dipanjan Karati, Kaustav K. Shaoo, Kakasaheb Mahadik, et al.
Results in Chemistry (2022) Vol. 4, pp. 100532-100532
Open Access | Times Cited: 12
GSK3β Substrate-competitive Inhibitors Regulate the gut Homeostasis and Barrier Function to Inhibit Neuroinflammation in Scopolamine-induced Alzheimer’s Disease Model Mice
Lingyu Zhang, Zhihao Jiang, Shaozhen Hu, et al.
Inflammation (2024)
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top